Fast Market Research

Global Autologous Cell Therapy Market 2017-2021 - New Study Released

Fast Market Research announces the availability of the new TechNavio report, "Global Autologous Cell Therapy Market 2017-2021", on their comprehensive research portal


Boston, MA -- (SBWIRE) -- 06/26/2017 -- Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

Technavio's analysts forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:


Technavio's report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Get More Details on this Report and a Full Table of Contents at Global Autologous Cell Therapy Market 2017-2021

Key vendors

-Brainstorm Cell Therapeutics
-Holostem Advanced Therapies
-Osiris Therapeutics
-Vericel Corporation

Other prominent vendors

-American CryoStem
-apceth Biopharma
-Astellas Pharma
-Baxter International
-Beike Biotechnology
-bluebird bio
-Bristol-Myers Squibb
-Caladrius Biosciences
-Cellular Biomedicine Group
-Cellular Dynamics International (a subsidiary of Fujifilm)
-Cesca Therapeutics
-CHA Biotech
-Chugai Pharmaceutical
-Cytori Therapeutics
-Daiichi Sankyo
-Gamida Cell
-Global Stem Cells Group
-Grupo Ferrer Internacional
-International Stem Cell
-Ivy Institute of Stem Cells
-Japan Regenerative Medicine
-Kangstem Biotech
-Kiadis Pharma
-Laboratorios Salvat
-Nuo Therapeutics
-Opsis Therapeutics
-Pluristem Therapeutics
-Promethera Biosciences
-Q Therapeutics
-Salus Medical Solutions
-Sangamo Therapeutics
-Steminent Biotherapeutics
-Sumitomo Dainippon Pharma
-Taiwan Bio Therapeutics
-Takeda Pharmaceutical
-Teva Pharmaceutical Industries
-Thoratec Corporation
-Translational Biosciences
-U.S. Stem Cell
-VistaGen Therapeutics

Market driver

-Increasing demand for effective drugs for cardiac and degenerative disorders
-For a full, detailed list, view our report

Market challenge

-Critical ethical challenges with respect to stem cell research
-For a full, detailed list, view our report

Market trend

-Private funding will fuel market growth
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Brainstorm Cell Therapeutics, Holostem Advanced Therapies, Osiris Therapeutics, Valeant, Vericel, AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, Brainxell, Caladrius Biosciences, Cellular Biomedicine, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, VistaGen Therapeutics

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape
-Stem Cell Therapy Market - Global Forecasts to 2021
-Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
-Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts
-Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016